Biology’s quiet revolution is underway, as single-cell tools fuel the next-wave of drug discoveries and promise to match therapies to the individual.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Computing cell state discriminates the aberrant hematopoiesis and activated microenvironment in Myelodysplastic syndrome (MDS) through a single cell genomic study
Journal of Translational Medicine Open Access 20 July 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sheridan, C. Can single-cell biology realize the promise of precision medicine?. Nat Biotechnol 42, 159–162 (2024). https://doi.org/10.1038/s41587-024-02138-x
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41587-024-02138-x
This article is cited by
-
Discovery of predictive biomarkers for cancer therapy through computational approaches
Nature Reviews Clinical Oncology (2026)
-
Research progress of single cell RNA sequencing in nervous system
Molecular Biology Reports (2026)
-
Computational drug repurposing: approaches, evaluation of in silico resources and case studies
Nature Reviews Drug Discovery (2025)
-
Computing cell state discriminates the aberrant hematopoiesis and activated microenvironment in Myelodysplastic syndrome (MDS) through a single cell genomic study
Journal of Translational Medicine (2024)
-
Contextual AI models for context-specific prediction in biology
Nature Methods (2024)